1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders-Reference-Cited by-同舟云学术

1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders

Published:2018-01-01 Issue:1 Volume:33 Page:665-670
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Benek Ondrej¹²³^ORCID,Hroch Lukas²^ORCID,Aitken Laura⁴^ORCID,Gunn-Moore Frank⁴^ORCID,Vinklarova Lucie¹²^ORCID,Kuca Kamil¹²^ORCID,Perez Daniel I.⁵^ORCID,Perez Concepcion⁶^ORCID,Martinez Ana⁵^ORCID,Fisar Zdenek⁷,Musilek Kamil¹²^ORCID

Affiliation:

1. University of Hradec Kralove, Faculty of Science, Department of Chemistry, Hradec Kralove, Czech Republic;

2. University Hospital in Hradec Kralove, Biomedical Research Center, Hradec Kralove, Czech Republic;

3. National Institute of Mental Health, Klecany, Czech Republic;

4. University of St. Andrews, Medical and Biological Sciences Building, School of Biology, St. Andrews, UK;

5. Centro de Investigaciones Biologicas-CSIC, Madrid, Spain;

6. Instituto de Quimica Medica-CSIC, Madrid, Spain;

7. Charles University and General University Hospital in Prague, First Faculty of Medicine, Department of Psychiatry, Prague, Czech Republic

Funder

Ministry of Health of the Czech Republic

National Institute of Mental Health

European Regional Development Fund

The Rosetrees trust

Biotechnology and Biological Sciences Research Council

Ministry of Economy and competitiveness

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2018.1445736

Reference17 articles.

1. Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases

2. Casein Kinase 1 Delta Phosphorylates Tau and Disrupts Its Binding to Microtubules

3. Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions

4. Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I

5. Identification of casein kinase-1 phosphorylation sites on TDP-43

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving significance of kinase inhibitors in the management of Alzheimer's disease;European Journal of Pharmacology;2024-09

2. Casein kinase (CK) inhibitors;Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy;2024

3. Nanomolar Benzothiazole-Based Inhibitors of 17β-HSD10 with Cellular Bioactivity;ACS Medicinal Chemistry Letters;2023-11-10

4. Frentizole derivatives with mTOR inhibiting and senomorphic properties;Biomedicine & Pharmacotherapy;2023-11

5. Development of submicromolar 17β-HSD10 inhibitors and their in vitro and in vivo evaluation;European Journal of Medicinal Chemistry;2023-10